The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment

Hepatocellular carcinoma (HCC) is one of most common cancers and the fourth leading cause of death worldwide. Commonly, HCC development occurs in a liver that is severely compromised by chronic injury or inflammation. Liver transplantation, hepatic resection, radiofrequency ablation (RFA), transcath...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Patrizia, Solimando, Antonio Giovanni, Fasano, Rossella, Argentiero, Antonella, Malerba, Eleonora, Buonavoglia, Alessio, Lupo, Luigi Giovanni, De Re, Valli, Silvestris, Nicola, Racanelli, Vito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160723/
https://www.ncbi.nlm.nih.gov/pubmed/34065489
http://dx.doi.org/10.3390/vaccines9050532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160723/
https://www.ncbi.nlm.nih.gov/pubmed/34065489
http://dx.doi.org/10.3390/vaccines9050532

Ejemplares similares